Seizure Medication recalls

The FDA has published 103 recalls involving seizure medication since 2012. The latest was reported on 9 Sep 2026. Most were for potency & assay. Aidapak Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls103since 2012

Last 12 months6reported

Class I66% of total

Ongoing17latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 2 0Feb 0 4 0May 1 0 0Aug 0 1 0Nov 0 0 0Feb 0 0 0May 0 3 2Aug 1 0

Severity split

Class I 6 6%Class II 80 78%Class III 17 17%

Why seizure medication is recalled

Companies

Brands

By year

202666%
202588%
202433%
202377%
202277%
202188%
202099%
201988%
201833%
201788%

Ongoing seizure medication recalls

17 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Trokendi XR, (topiramate) extended-release capsules, 50 mg recalled	Supernus Pharmaceuticals	Potency & Assay	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalled	SUN Pharmaceutical Industries	Manufacturing (CGMP) Deviations	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalledCarbamazepine	Golden State Medical Supply	Manufacturing (CGMP) Deviations	Nationwide
29 Jul 2026Drug	CLASS II	Divalproex Sodium Delayed-Release Tablets, USP, 500 mg recalledDivalproex Sodium	Bionpharma	Other	Nationwide
29 Jul 2026Drug	CLASS III	Trokendi XR, topiramate extended-release capsules, 25mg recalled	Supernus Pharmaceuticals	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma PrivateLacosamide	Annora Pharma Private	Packaging Defects	Nationwide

All seizure medication recalls, newest first

103 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Trokendi XR, (topiramate) extended-release capsules, 50 mg recalled	Supernus Pharmaceuticals	Potency & Assay	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalled	SUN Pharmaceutical Industries	Manufacturing (CGMP) Deviations	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalledCarbamazepine	Golden State Medical Supply	Manufacturing (CGMP) Deviations	Nationwide
29 Jul 2026Drug	CLASS II	Divalproex Sodium Delayed-Release Tablets, USP, 500 mg recalledDivalproex Sodium	Bionpharma	Other	Nationwide
29 Jul 2026Drug	CLASS III	Trokendi XR, topiramate extended-release capsules, 25mg recalled	Supernus Pharmaceuticals	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma PrivateLacosamide	Annora Pharma Private	Packaging Defects	Nationwide
8 Oct 2025Drug	CLASS II	Carbamazepine Extended-Release Tablets recalledCarbamazepine	Amerisource Health Services	Potency & Assay	Nationwide
11 Jun 2025Drug	CLASS II	Lacosamide Oral Solution, USP, 10 mg/mL recalled by Apotex	Apotex	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS II	Lacosamide Tablets, 50mg recalled by Glenmark PharmaceuticalsLacosamide	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
16 Apr 2025Drug	CLASS II	Lacosamide Tablets 200mg recalled by Glenmark PharmaceuticalsLacosamide	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
16 Apr 2025Drug	CLASS II	Lacosamide Tablets, 100mg recalled by Glenmark PharmaceuticalsLacosamide	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
16 Apr 2025Drug	CLASS II	Lacosamide Tablets 150mg recalled by Glenmark PharmaceuticalsLacosamide	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
22 Jan 2025Drug	CLASS II	Clobazam Tablets, 10 mg recalled by Amerisource Health ServicesClobazam	Amerisource Health Services	Packaging Defects	Nationwide
15 Jan 2025Drug	CLASS II	Clobazam Tablets, 10 mg recalled by Amerisource Health ServicesClobazam	Amerisource Health Services	Packaging Defects	Nationwide
3 Apr 2024Drug	CLASS II	Divalproex Sodium Extended-release Tablets, USP 250 mg recalledDivalproex Sodium	Amneal Pharmaceuticals of New York	Potency & Assay	Nationwide
28 Feb 2024Drug	CLASS II	Clobazam Tablets 10mg recalled by Micro LabsClobazam	Micro Labs	Potency & Assay	Nationwide
10 Jan 2024Drug	CLASS III	Eprontia (topiramate) oral solution, 25 mg/mL recalledEprontia	Azurity Pharmaceuticals	Potency & Assay	Nationwide
27 Dec 2023Drug	CLASS I	Phenytoin Oral Suspension, USP, 100 mg recalled	The Harvard Drug Group	Packaging Defects	Nationwide
15 Nov 2023Drug	CLASS II	Extended Phenytoin Sodium Capsules, USP, 100 mg recalledExtended Phenytoin Sodium	Amneal Pharmaceuticals of New York	Potency & Assay	Nationwide
21 Jun 2023Drug	CLASS II	Extended Phenytoin Sodium Capsules, USP, 100 mg recalledExtended Phenytoin Sodium	Amneal Pharmaceuticals of New York	Potency & Assay	LA, OH, PA
7 Jun 2023Drug	CLASS II	Oxcarbazepine Oral Suspension, USP, 300 mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
7 Jun 2023Drug	CLASS II	Levetiracetam Oral Solution 100 mg/mL (100 mg/mL) recalled by Akorn	Akorn	Potency & Assay	Nationwide
22 Mar 2023Drug	CLASS II	Clobazam Tablets, 20 mg, CIV recalled by Breckenridge Pharmaceutical	Breckenridge Pharmaceutical	Manufacturing (CGMP) Deviations	Nationwide
22 Mar 2023Drug	CLASS II	Clobazam Tablets, 10 mg, CIV recalled by Breckenridge Pharmaceutical	Breckenridge Pharmaceutical	Manufacturing (CGMP) Deviations	Nationwide
28 Dec 2022Drug	CLASS II	Oxcarbazepine Tablets 600mg recalled by Sun Pharmaceutical IndustriesOxcarbazepine	SUN Pharmaceutical Industries	Packaging Defects	Nationwide
21 Dec 2022Drug	CLASS III	Lacosamide Oral Solution, USP, CV, 10mg/mL recalledLacosamide	Camber Pharmaceuticals	Potency & Assay	Nationwide
31 Aug 2022Drug	CLASS II	Divalproex Sodium Extended Release Tablets, USP, 250 mg recalledDivalproex Sodium	Amneal Pharmaceuticals of New York	Potency & Assay	Nationwide
17 Aug 2022Drug	CLASS III	Lamotrigine Tablets, USP 100 mg recalled by AVKARELamotrigine	Avkare	Other	Nationwide
3 Aug 2022Drug	CLASS II	Divalproex Sodium Delayed-Release Tablets, USP 500mg recalledDivalproex Sodium	SUN Pharmaceutical Industries	Potency & Assay	Nationwide
26 Jan 2022Drug	CLASS II	Clobazam Oral Suspension 2.5 mg/mL recalled by VistaPharm	VistaPharm	Potency & Assay	Nationwide

Should you stop taking Seizure Medication?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.